NCT01917019 - A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis | Biotech Hunter

Enrollment

101

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

March 31, 2017

Conditions

Multiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisMultiple Sclerosis

Interventions

DRUG

Placebo

matching placebo tablets

DRUG

BIIB041 (fampridine)

fampridine prolonged-release tablets

Trial Locations (19)

Unknown

Research Site, Bunkyō City

Research Site, Chiba

Research Site, Fuchū

Research Site, Fukuoka

Research Site, Kawagoe-shi

Research Site, Kodaira-shi

Research Site, Kyoto

Research Site, Morioka

Research Site, Niigata

Research Site, Obihiro

Research Site, Osaka

Research Site, Ōta-ku

Research Site, Sapporo

Research Site, Sendai

Research Site, Shinjuku-ku

Research Site, Suita-shi

Research Site, Toon-shi

Research Site, Ube-shi

Research Site, Yachiyo-shi